Can Gemcitabine Instillation Ablate Solitary Low-Risk Non-Muscle-Invasive Bladder Cancer? Results of a Phase II Marker Lesion Study

Publisher： Karger

E-ISSN： 1423-0399|87|4|470-474

ISSN： 0042-1138

Source： Urologia Internationalis, Vol.87, Iss.4, 2011-11, pp. : 470-474

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Intravesical bacillus Calmette–Guérin instillation in non‐muscle‐invasive bladder cancer: A review

By  

INTERNATIONAL JOURNAL OF UROLOGY, Vol. 25, Iss. 1, 2018-01 ,pp. : 18-24

John Wiley & Sons Inc

Access to resources Recommend Favorite

Diagnosis and treatment of non‐muscle‐invasive bladder cancer

By  

TRENDS IN UROLOGY AND MEN'S HEALTH, Vol. 6, Iss. 2, 2015-03 ,pp. : 23-27

John Wiley & Sons Inc

Access to resources Recommend Favorite

Recurrence and Progression in Non-Muscle-Invasive Bladder Cancer Using EORTC Risk Tables

By  

Urologia Internationalis, Vol. 89, Iss. 1, 2012-06 ,pp. : 61-66

Karger

Access to resources Recommend Favorite

Is Urinary Soluble Fas an Independent Predictor of Non-Muscle-Invasive Bladder Cancer? A Prospective Chart Study

By  

Urologia Internationalis, Vol. 91, Iss. 4, 2013-08 ,pp. : 456-461

Karger

Access to resources Recommend Favorite

Ablative Intravesical Chemotherapy for Small Recurrent Non-Muscle-Invasive Bladder Cancer: A Prospective Study

By  

Urologia Internationalis, Vol. 96, Iss. 1, 2016-0 ,pp. : 14-19

Karger

Access to resources Recommend Favorite